MohammadAnwarulKabirMD
Cardiology • Dayton, OHAdult Congenital Heart Disease, Interventional Cardiology
Physician
Are you Dr. Kabir?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 53 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
7111 N Main St
Suite 50
Dayton, OH 45415Phone+1 937-424-5986Fax+1 937-424-5989
Summary
- Dr. Mohammad Kabir, MD is a cardiologist in Dayton, Ohio. He is currently licensed to practice medicine in Ohio, Georgia, and Wisconsin. He is affiliated with Good Samaritan Hospital and Soin Medical Center.
Education & Training
New York Medical College at St Vincent's Hospital and Medical Center of New YorkFellowship, Interventional Cardiology, 2009 - 2010
Chicago Medical School/Rosalind Franklin University of Medicine & ScienceFellowship, Cardiovascular Disease, 2007 - 2009
Wright State UniversityFellowship, Cardiovascular Disease, 2006 - 2007- Wright State UniversityResidency, Internal Medicine, 1995 - 1998
Sylhet Mag Osmani Medical CollegeClass of 1989
Certifications & Licensure
GA State Medical License 2018 - 2026
OH State Medical License 1998 - 2026
NY State Medical License 1974 - 2020
CA State Medical License 1981 - 2019
WI State Medical License 2016 - 2019
IL State Medical License 2007 - 2011- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 12 citationsAcetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53.Md Kabir, Ning Sun, Xiaoping Hu, Tiphaine C Martin, Jingjie Yi
Journal of the American Chemical Society. 2023-07-12 - 15 citationsPyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties.Ganesha Rai, Daniel J. Urban, Bryan T. Mott, Xin Hu, Shyh-Ming Yang
Journal of Medicinal Chemistry. 2020-09-09 - 4 citationsIdentification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform.Md Kabir, Elias C Padilha, Pranav Shah, Ruili Huang, Srilatha Sakamuru
Frontiers in Pharmacology. 2022-01-01
Press Mentions
Around 9 Lakh Girls to Get HPV Vaccines in Rajshahi DivisionOctober 19th, 2024
